Case todayNot read todayThesis-Break EngineThe case · mixed · Oct 24, 2026Own MNDR if MNDR is a speculative mobile-health software turnaround whose value depends on proving that demand, gross margin, and cash burn can recover together before liquidity forces dilution.4 conditions2 holding · 2 weakeningNext resultsNot scheduledNo date filed yet

MNDR at a glance

The past year

Chart

−46.4% $0.95, close Nov 18

From the highest close
−80.0%
Vs the 200-day average
−27.4%
Nov 17, 2025Daily close, Mobile-health Network SolutionsNov 18, 2026

Short interest

History

79,652 shares

Since the last report
+197.5%
Days to cover
1.0 day
Settled
Oct 30, 2026

Insider buying, 7 days

Filings

None filed this week

Form 4s filed
Nov 13 – Nov 19

Understand the Business

Why the Stock Moved

Period-matched expectations history is not yet available. Current metrics are not a substitute for a historical explanation.

MNDR price history

Latest price$0.98Today+$0.03 (+2.89%)
MNDR +6.84%S&P 500 -5.85%Since first plotted close
4 hours

Loading recent earnings…

Investment thesis

What must happen next

4 MATERIAL PROPOSITIONS
  • Customers must treat MNDR’s mobile-health offering as a necessary access or workflow channel rather than discretionary digital-health spend, so lost demand can return without the company buying growth through discounts or promotions.WeakeningMateriality: High

    GAAP annual revenue rose from $7.9 million in FY2023 ended June 30, 2023 to $14.0 million in FY2024 ended June 30, 2024, showing the platform has previously attracted materially higher demand. If customer pull returns, MNDR can rebuild the revenue base; if demand is structurally weak, the company remains too small to absorb fixed public-company and platform costs.

    Watch: Healthcare customers standardize on hospital-owned telehealth portals or insurer/pharmacy apps instead of using MNDR’s platform.

    Supporting sources

    Source notes are factual paraphrases; read the original disclosures below.

    GAAP annual revenue rose from $7.9 million in FY2023 ended June 30, 2023 to $14.0 million in FY2024 ended June.

    Open source ↗
  • MNDR needs enough platform differentiation, network control, or workflow value to avoid commodity pricing and provider-cost pressure; otherwise revenue recovery would not translate into attractive unit economics.HoldingMateriality: High

    GAAP annual gross profit increased from $1.1 million in FY2023 ended June 30, 2023 to $2.5 million in FY2024 ended June 30, 2024 during the revenue upswing. Gross-profit quality determines whether growth can fund product, sales, and public-company costs instead of increasing losses.

    Watch: Competing telehealth and healthcare-software platforms force MNDR to cut prices to retain customers.

    Supporting sources

    Source notes are factual paraphrases; read the original disclosures below.

    GAAP annual gross profit increased from $1.1 million in FY2023 ended June 30, 2023 to $2.5 million in FY2024 ended.

    Open source ↗
  • MNDR’s turnaround requires enough liquidity or non-punitive financing to bridge the period until demand and unit economics improve; otherwise capital structure, not product adoption, will drive shareholder outcomes.WeakeningMateriality: Medium

    Cash was positive at $1.0 million as of June 30, 2025. A good operating recovery can still be poor for current owners if it is financed through distressed dilution.

    Watch: MNDR cannot raise equity or debt on acceptable terms before the business reaches cash breakeven.

    Supporting sources

    Source notes are factual paraphrases; read the original disclosures below.

    Cash was positive at $1.0 million as of June 30, 2025.

    Open source ↗
  • Management must turn the lower loss profile into a structural operating model improvement, not merely a smaller loss after cutting activity; otherwise MNDR remains dependent on external capital even if revenue stabilizes.HoldingMateriality: Medium

    GAAP annual operating cash flow improved from negative $6.4 million in FY2024 ended June 30, 2024 to negative $4.4 million in FY2025 ended June 30, 2025. The owner needs evidence that the platform can self-fund; persistent cash burn transfers value from shareholders to future capital providers.

    Watch: Customer acquisition costs rise because MNDR must spend heavily to rebuild demand after the FY2025 revenue decline.

    Supporting sources

    Source notes are factual paraphrases; read the original disclosures below.

    GAAP annual operating cash flow improved from negative $6.4 million in FY2024 ended June 30, 2024 to negative $4.4 million.

    Open source ↗
Full investment case & evidence

Loading the original research archive…

Original research

Customers must treat MNDR’s mobile-health offering as a necessary access or workflow channel rather than discretionary digital-health spend, so lost demand can return without the company buying growth through discounts or promotions. If customer pull returns, MNDR can rebuild the revenue base; if demand is structurally weak, the company remains too small to absorb fixed public-company and platform costs.

MNDR needs enough platform differentiation, network control, or workflow value to avoid commodity pricing and provider-cost pressure; otherwise revenue recovery would not translate into attractive unit economics. Gross-profit quality determines whether growth can fund product, sales, and public-company costs instead of increasing losses.

MNDR’s turnaround requires enough liquidity or non-punitive financing to bridge the period until demand and unit economics improve; otherwise capital structure, not product adoption, will drive shareholder outcomes. A good operating recovery can still be poor for current owners if it is financed through distressed dilution.

Management must turn the lower loss profile into a structural operating model improvement, not merely a smaller loss after cutting activity; otherwise MNDR remains dependent on external capital even if revenue stabilizes. The owner needs evidence that the platform can self-fund; persistent cash burn transfers value from shareholders to future capital providers.

All standing thesis claims
Original report summary

MNDR is a speculative mobile-health software turnaround whose value depends on proving that demand, gross margin, and cash burn can recover together before liquidity forces dilution.

Evidence assessed Oct 24, 2026. Expand each conclusion for its evidence and what would change it. Thesis evidence—not a buy or sell recommendation.

Bull case and bear case

Bull case and bear case for Mobile-health Network Solutions

Where the evidence on Mobile-health Network Solutions disagrees: Mixed on the latest evidence (Oct 24, 2026). Of its 4 thesis points, 2 holding and 2 weakening.

Bull case: what the evidence supports

  • MNDR needs enough platform differentiation, network control, or workflow value to avoid commodity pricing and provider-cost pressure; otherwise revenue recovery would not translate into attractive unit economics.

    sec.gov ↗

  • Management must turn the lower loss profile into a structural operating model improvement, not merely a smaller loss after cutting activity; otherwise MNDR remains dependent on external capital even if revenue stabilizes.

    sec.gov ↗

Bear case: what the evidence questions

  • Customers must treat MNDR’s mobile-health offering as a necessary access or workflow channel rather than discretionary digital-health spend, so lost demand can return without the company buying growth through discounts or promotions.

    sec.gov ↗

  • MNDR’s turnaround requires enough liquidity or non-punitive financing to bridge the period until demand and unit economics improve; otherwise capital structure, not product adoption, will drive shareholder outcomes.

    sec.gov ↗

Thesis-Break Engine

Thesis-break watch · Mobile-health Network Solutions

12 mo agonow
Trailing daily price. No thesis break has crossed here, so there is no break base rate to project.

No break has crossed Mobile-health Network Solutions’s thesis. Its break conditions are checked against every new filing as it lands.

How the Thesis-Break Engine works →Historical outcomes are measured against the market after past breaks of the same kind, across all companies. Not a prediction.

MARKET + FINANCIAL SNAPSHOT

The numbers behind the thesis

Sourced from filings and market data

What Changed

  1. Mixed
    Foreign issuer material report (6-K).

    Mobile-health Network Solutions filed an SEC report on 2026-09-25: Foreign issuer material report (6-K). It is a dated development that tests the current thesis.

  2. Mixed
    Foreign issuer material report (6-K).

    Mobile-health Network Solutions filed an SEC report on 2026-08-18: Foreign issuer material report (6-K). It is a dated development that tests the current thesis.

  3. Mixed
    Foreign issuer material report (6-K).

    Mobile-health Network Solutions filed an SEC report on 2026-08-12: Foreign issuer material report (6-K). It is a dated development that tests the current thesis.

Risks / falsifiers

What could break the thesis

  • Healthcare customers standardize on hospital-owned telehealth portals or insurer/pharmacy apps instead of using MNDR’s platform.
  • Competing telehealth and healthcare-software platforms force MNDR to cut prices to retain customers.
  • MNDR cannot raise equity or debt on acceptable terms before the business reaches cash breakeven.
  • Customer acquisition costs rise because MNDR must spend heavily to rebuild demand after the FY2025 revenue decline.

MNDR news

Loading headlines…

Financial statements

MNDR income statement

Annual filed results · USD · Oldest to newest. Margins are calculated from the reported figures.

MNDR: quick answers

What is MNDR's short interest?
As of October 30, 2026, 79,652 MNDR shares were sold short, up 197.5% from the count before. At the stock's average daily volume that is 1.0 day to cover. FINRA publishes the count twice a month. MNDR short interest history
ScoutJUST THIS STORY

LET’S MAKE THIS USEFUL · 1 OF 5

How would you like me to explain this?

Tell me what you want from this read. Start with a quick note, then adjust the details. Your other stories stay as they are.

We’ll remember your view of this story. The published article stays unchanged.

THIS STORY’S READING VIEWStandard · The whole picture

Clear explanations with context. Both sides of the evidence.